Literature DB >> 3635415

Primary treatment of hairy cell leukemia: should IFN-therapy replace splenectomy?

F Porzsolt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3635415     DOI： 10.1007/BF00320789

Source DB:  PubMed          Journal:  Blut        ISSN： 0006-5242


× No keyword cloud information.
  28 in total

1.  Deaths halt interferon trials in France.

Authors:  D Dickson
Journal:  Science       Date:  1982-11-19       Impact factor: 47.728

2.  Prognosis and therapy in hairy cell leukemia.

Authors:  J Jansen; G J den Ottolander; R S Holdrinet; G J Tricot; J Hermans
Journal:  Semin Oncol       Date:  1984-12       Impact factor: 4.929

3.  Hairy cell leukemia: a comparative study of Japanese and non-Japanese patients.

Authors:  I Katayama; T Mochino; T Honma; M Fukuda
Journal:  Semin Oncol       Date:  1984-12       Impact factor: 4.929

4.  Hairy cell leukemia: clinical presentation and follow-up of 211 patients.

Authors:  G Flandrin; F Sigaux; G Sebahoun; P Bouffette
Journal:  Semin Oncol       Date:  1984-12       Impact factor: 4.929

5.  A chronic lymphoproliferative disorder with distinctive features: a distinct variant of hairy-cell leukaemia.

Authors:  J C Cawley; G F Burns; F G Hayhoe
Journal:  Leuk Res       Date:  1980       Impact factor: 3.156

6.  Host defence factors and prognosis in hairy cell leukemia.

Authors:  E M Hersh; J Quesada; M J Keating; S Rasmussen; S G Murphy; C Gschwind; J Morgan
Journal:  Leuk Res       Date:  1982       Impact factor: 3.156

7.  Alpha interferon treatment of patients with hairy-cell leukaemia.

Authors:  H Hagberg; G Alm; M Björkholm; B Glimelius; A Killander; B Simonsson; C Sundström; A Ahre
Journal:  Scand J Haematol       Date:  1985-07

8.  Treatment of hairy cell leukemia with recombinant alpha 2 interferon.

Authors:  M J Ratain; H M Golomb; J W Vardiman; E E Vokes; R H Jacobs; K Daly
Journal:  Blood       Date:  1985-03       Impact factor: 22.113

9.  Phase-I trial of UltrapureTM human leukocyte interferon in human malignancy.

Authors:  G T Budd; R M Bukowski; L Miketo; B Yen-Lieberman; M R Proffitt
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

10.  Clinical staging system for hairy-cell leukemia.

Authors:  J Jansen; J Hermans
Journal:  Blood       Date:  1982-09       Impact factor: 22.113
View more
  5 in total

1.  The effect of interferons on cellular differentiation.

Authors:  T Moritz; H Kirchner
Journal:  Blut       Date:  1986-11

Review 2.  Hairy cell leukemia: clinical features and therapeutic advances.

Authors:  B C Lembersky; H M Golomb
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

3.  Treatment of advanced renal cell cancer with recombinant interferon alpha as a single agent and in combination with medroxyprogesterone acetate. A randomized multicenter trial.

Authors:  F Porzsolt; D Messerer; R Hautmann; A Gottwald; H Sparwasser; K Stockamp; W Aulitzky; J G Moormann; K Schumacher; H Rasche
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

4.  Rationale for combining tamoxifen and interferon in the treatment of advanced breast cancer.

Authors:  F Porzsolt; A M Otto; B Trauschel; C Buck; A W Wawer; H Schönenberger
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

5.  [Beta interferon therapy in hairy cell leukemia].

Authors:  P von Wussow; J Dühlmann; T Grethlein; W D Hirschmann; E Hügl; O Koch; W R Martin; H W Pees; W Urbanitz; M Freund
Journal:  Klin Wochenschr       Date:  1987-07-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.